Unilever to Weigh Raising Offer for Glaxo Consumer Unit
- Dove owner could sell some Glaxo assets to buyout firms
- Pharma giant rejected $68 billion offer, latest of three bids
This article is for subscribers only.
Unilever Plc has held talks with banks about additional financing for a potential sweetened offer for GlaxoSmithKline Plc’s consumer products division, according to people familiar with the matter.
Some financial firms have discussed lending enough for a bid higher than 50 billion pounds ($68 billion) -- the latest of three offers Glaxo has rejected for a bundle of brands including Advil painkiller and Sensodyne toothpaste.